产品名称

英文名称：(R)-6-(4-Aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one

同义词

(4R)-3-(4-Aminophenyl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one 、 O-Desmethyl Tramadol ?-D-Glucuronide 、 OR1855 、 OR-1855 、 YM 09730-5 、 6-(4-Aminophenyl)-4,5-dihydro-5-mehtyl-3(2H)-pyridazinone 、 CHEBI193746 、 HY-W050000 、 (R)-6-(4-aminophenyl)-5-methyl-

产品性质

CAS编号：101328-85-2

分子式：C11H13N3O

分子量：203.24

PubChem编号：10465484

英文别名：(4R)-3-(4-Aminophenyl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one | O-Desmethyl Tramadol ?-D-Glucuronide | OR1855 | OR-1855 | YM 09730-5 | 6-(4-Aminophenyl)-4,5-dihydro-5-mehtyl-3(2H)-pyridazinone | CHEBI193746 | HY-W050000 | (R)-6-(4-aminophenyl)-5-methyl-

规格或纯度：98%

英文名称：(R)-6-(4-Aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one

储存温度：避光,-20°C储存

运输条件：超低温冰袋运输

产品介绍：OR-1855 是 Levosimendan 的活性代谢产物，对人体肌层收缩力有影响。Levosimendan 是一种钙敏感性活性分子，用于急性失代偿性充血性心力衰竭的相关研究。OR-1855, an active metabolite of Levosimendan, has effect on human myometrial contractility. Levosimendan is a calcium sensitiser used in the management of acutely decompensated congestive heart failure.

IUPAC Name：(4R)-3-(4-aminophenyl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one

INCHI：InChI=1S/C11H13N3O/c1-7-6-10(15)13-14-11(7)8-2-4-9(12)5-3-8/h2-5,7H,6,12H2,1H3,(H,13,15)/t7-/m1/s1

InChi Key：GDMRFHZLKNYRRO-SSDOTTSWSA-N

Canonical SMILES：CC1CC(=O)NN=C1C2=CC=C(C=C2)N

Isomeric SMILES：C[C@@H]1CC(=O)NN=C1C2=CC=C(C=C2)N

PubChem CID：10465484

敏感性：对光线敏感

信号词：Warning

危险声明：H315 Causes skin irritationH319 Causes serious eye irritationH335 May cause respiratory irritationH302 Harmful if swallowed

预防措施声明：P261,P305+P351+P338

产品包装